Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Regulatory securities fraud

Hims & Hers Securities Fraud Class Action

Analysis based on 215 articles · First reported Jul 29, 2026 · Last updated Sep 22, 2026

Sentiment
-20
Attention
4
Articles
215
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The securities class action and the underlying FTC lawsuit have already caused a sharp decline in Hims & Hers stock, and the ongoing litigation could lead to further volatility and potential financial penalties. The case highlights regulatory risks in the telehealth sector, potentially affecting investor sentiment toward similar companies and prompting increased scrutiny of data privacy and billing practices.

telehealth pharmaceuticals legal services

Hims & Hers Health, Inc. and certain executives face a securities fraud class action lawsuit filed in the Northern District of United States — California (Velanki v. Hims & Hers Health, Inc., No. 26-cv-09313). The lawsuit alleges that during the class period from August 4, 2025 to July 29, 2026, the company made materially false and misleading statements and failed to disclose that it shared consumers' health information with third-party advertising platforms, charged consumers for prescriptions almost immediately after they submitted intake forms despite promising consultation with medical providers, and that these practices subjected the company to regulatory scrutiny and likely penalties. The lawsuit was triggered by the United States — Federal Trade Commission's July 29, 2026 lawsuit against Hims & Hers, joined by the State of United States — Utah and United States — Los Angeles County, California (representing United States — California), which accused the company of deceptive privacy and billing practices. On that news, Hims & Hers shares fell $4.32, or 14.73%, to close at $25.00, erasing over $970 million in market capitalization. The lead plaintiff deadline is November 2, 2026. Additionally, Visa Inc. reportedly placed Hims & Hers in its Acquirer Monitoring Program due to excessive customer complaints, resulting in surcharges. The company has disputed the FTC's claims, and CEO Andrew Dudum has defended its business model. The FTC has also pursued similar cases against other telehealth companies like BetterHelp and GoodRx.

stock
Hims & Hers is the central defendant in the securities class action and the FTC lawsuit, facing allegations of deceptive practices that have already caused a significant stock drop and reputational damage. The outcome could result in financial penalties and changes to its business operations.
Importance 100.0 Sentiment -60.0
govactor
The FTC filed the lawsuit against Hims & Hers that triggered the securities class action, alleging deceptive privacy and billing practices. Its actions are driving regulatory scrutiny in the telehealth industry.
Importance 90.0 Sentiment 0.0
per
CEO Andrew Dudum has publicly defended Hims & Hers against the FTC lawsuit, stating the allegations stem from a misunderstanding of the company's healthcare model. His leadership is under scrutiny amid the legal challenges.
Importance 50.0 Sentiment -20.0
loc
United States — Utah joined the FTC lawsuit as a co-plaintiff, representing state-level consumer protection interests against Hims & Hers.
Importance 40.0 Sentiment 0.0
loc
United States — Los Angeles County, California joined the FTC lawsuit on behalf of United States — California, adding local government weight to the allegations against Hims & Hers.
Importance 40.0 Sentiment 0.0
govactor
The court is the venue for the securities class action lawsuit against Hims & Hers, where legal proceedings will determine liability and potential damages. Its rulings will impact the company's financial and legal standing.
Importance 30.0 Sentiment 0.0
stock
Meta Platforms is named as one of the third-party advertising platforms that allegedly received consumers' health information from Hims & Hers, raising privacy concerns.
Importance 30.0 Sentiment -10.0
loc
United States — California is represented in the FTC lawsuit through United States — Los Angeles County, California, reflecting state involvement in the case against Hims & Hers.
Importance 30.0 Sentiment 0.0
stock
Snap Inc. is named as one of the third-party advertising platforms that allegedly received consumers' health information from Hims & Hers, raising privacy concerns.
Importance 30.0 Sentiment -10.0
priv
Reported on Visa's monitoring program for Hims & Hers, adding to negative news coverage and investor scrutiny.
Importance 20.0 Sentiment 0.0
priv
Alleged recipient of Hims & Hers user data via tracking pixels; faces reputational risk but no direct legal action.
Importance 20.0 Sentiment -5.0
per
Howard G. Smith leads a law firm investigating Hims & Hers for potential securities law violations. He represents investor interests.
Importance 20.0 Sentiment 0.0
per
Frank R. Cruz leads a law firm investigating Hims & Hers for potential securities law violations. He represents investor interests.
Importance 20.0 Sentiment 0.0
priv
Filed and publicized the securities class action against Hims on behalf of investors.
Importance 20.0 Sentiment 0.0
priv
Investigating and publicizing the securities class action tied to the FTC complaint against Hims.
Importance 20.0 Sentiment 0.0
+ 29 more entities View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.